Cleerly LABS vs Tyto Stethoscope

Tyto Stethoscope is designed for a broader user base, including patients and general practitioners, with a handheld device and guided examination process for remote physical exams. Cleerly LABS, while web-based, is a specialized diagnostic tool for cardiologists and radiologists, requiring CCTA data and professional interpretation, making it less broadly 'usable' in a general sense. The intuitive, guided nature of TytoCare's device and app makes it more accessible for diverse users and remote settings.

Cleerly LABS provides deep, quantitative insights into coronary artery disease by detecting, quantifying, and characterizing atherosclerosis and stenosis, directly addressing a leading cause of mortality. Its focus on personalized heart disease management and preventing heart attacks through detailed plaque analysis offers a highly specialized and impactful clinical value. While Tyto Stethoscope offers broad remote examination capabilities, Cleerly's specific diagnostic precision in a critical area gives it an edge in specialized clinical impact.

Tyto Stethoscope offers a more transparent and generally lower entry cost, particularly with its TytoHome consumer version priced around $299-$300 for a one-time purchase. Cleerly LABS is significantly more expensive per analysis, with a retail price of $1500 (discounted to $750), and the total cost including the CCTA scan can be substantial and often out-of-pocket. TytoCare's clear, lower upfront pricing for its consumer model provides better value accessibility.

Both tools are FDA-cleared, HIPAA compliant, and offer BAAs, indicating foundational enterprise readiness. However, Cleerly LABS explicitly highlights integration capabilities with PACS, RIS, and EHR via its Cleerly Proxy, which is crucial for seamless integration into existing hospital and radiology/cardiology workflows. While TytoCare supports telehealth workflows, Cleerly's specific mention of these core system integrations gives it a stronger position for enterprise deployment in complex healthcare IT environments.

Cleerly LABS demonstrates significant innovation by moving beyond traditional stenosis measurement to provide comprehensive AI-powered analysis of coronary plaque volume and type from CCTA, aiming to redefine heart attack prevention. This approach offers a novel and more predictive understanding of cardiovascular risk. While Tyto Stethoscope innovates in consolidating multiple remote physical exam capabilities, Cleerly's deeper dive into personalized disease understanding and prevention represents a more transformative shift in diagnostic imaging and cardiovascular care.

Neither the provided structured facts nor general web searches yielded specific comparative details regarding the level of support, documentation quality, or service level agreements for either Cleerly LABS or Tyto Stethoscope. Without concrete information to differentiate them, it is not possible to definitively pick a winner in this dimension.